259 related articles for article (PubMed ID: 2290166)
1. Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.
Holtman JH; Neustadt DH; Klein J; Callen JP
J Rheumatol; 1990 Sep; 17(9):1222-5. PubMed ID: 2290166
[TBL] [Abstract][Full Text] [Related]
2. Subacute cutaneous lupus associated with Hashimoto's thyroiditis.
Ilan Y; Ben Yehuda A
Neth J Med; 1991 Aug; 39(1-2):105-7. PubMed ID: 1961346
[TBL] [Abstract][Full Text] [Related]
3. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings.
Sontheimer RD
Autoimmun Rev; 2005 Jun; 4(5):253-63. PubMed ID: 15990071
[TBL] [Abstract][Full Text] [Related]
4. Classification of lupus erythematosus based upon Japanese patients.
Tsuchida T
Autoimmun Rev; 2009 May; 8(6):453-5. PubMed ID: 19162249
[TBL] [Abstract][Full Text] [Related]
5. Subacute cutaneous lupus erythematosus in multiple members of a family with C2 deficiency.
Callen JP; Hodge SJ; Kulick KB; Stelzer G; Buchino JJ
Arch Dermatol; 1987 Jan; 123(1):66-70. PubMed ID: 3467658
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
Walling HW; Sontheimer RD
Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
[TBL] [Abstract][Full Text] [Related]
7. Urticarial vasculitis in systemic lupus erythematosus: fair response to prednisolone/dapsone and persistent hypocomplementemia.
Nishijima C; Hatta N; Inaoki M; Sakai H; Takehara K
Eur J Dermatol; 1999; 9(1):54-6. PubMed ID: 9920991
[TBL] [Abstract][Full Text] [Related]
8. Annular subacute cutaneous lupus erythematosus lesions and polymyositis onset in a patient with primary Sjogren's syndrome: how should this unusual association be classified?
Bernacchi E; Neri R; Caproni M; Loggini B; Fabbri P; Bombardieri S
Lupus; 2013 Mar; 22(3):312-5. PubMed ID: 23358869
[TBL] [Abstract][Full Text] [Related]
9. [Subacute cutaneous lupus erythematosus: clinical aspects, immunology and therapy].
Ruzicka T; Bieber T; Meurer M
Wien Klin Wochenschr; 1987 Dec; 99(23):802-7. PubMed ID: 3324494
[TBL] [Abstract][Full Text] [Related]
10. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
[TBL] [Abstract][Full Text] [Related]
11. [Classification of dermatologic manifestations in lupus erythematosus].
Francès C; Barete S; Ayoub N; Piette JC
Ann Med Interne (Paris); 2003 Feb; 154(1):33-44. PubMed ID: 12746657
[TBL] [Abstract][Full Text] [Related]
12. [Gastrointestinal involvement and the response to dapsone in a case of the urticarial vasculitis syndrome].
González Quijada S; López Lázaro L; Reinares García L; Borregón Carretero SJ; Sastre Varela J; Estrada Pérez V
Med Clin (Barc); 1991 Nov; 97(18):706-8. PubMed ID: 1770822
[TBL] [Abstract][Full Text] [Related]
13. Clinical course and prognosis of cutaneous lupus erythematosus.
Tebbe B
Clin Dermatol; 2004; 22(2):121-4. PubMed ID: 15234012
[TBL] [Abstract][Full Text] [Related]
14. The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2/C4 deficiency.
Boeckler P; Milea M; Meyer A; Uring-Lambert B; Heid E; Hauptmann G; Cribier B; Lipsker D
Br J Dermatol; 2005 Feb; 152(2):265-70. PubMed ID: 15727637
[TBL] [Abstract][Full Text] [Related]
15. [Subacute cutaneous lupus erythematosus].
Jore S; Gran JT
Tidsskr Nor Laegeforen; 1997 May; 117(14):2040-2. PubMed ID: 9235684
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.
Marzano AV; Lazzari R; Polloni I; Crosti C; Fabbri P; Cugno M
Br J Dermatol; 2011 Aug; 165(2):335-41. PubMed ID: 21564069
[TBL] [Abstract][Full Text] [Related]
17. Lupus erythematosus associated with erythema multiforme: report of two cases and review of the literature.
Aydogan K; Karadogan S; Balaban Adim S; Tunali S
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):621-7. PubMed ID: 16164723
[TBL] [Abstract][Full Text] [Related]
18. Hereditary C2 deficiency associated with cutaneous lupus erythematosus: clinical, laboratory, and genetic studies.
Levy SB; Pinnell SR; Meadows L; Snyderman R; Ward FE
Arch Dermatol; 1979 Jan; 115(1):57-61. PubMed ID: 760659
[TBL] [Abstract][Full Text] [Related]
19. [Association of systemic lupus erythematosus and Sjögren's syndrome].
Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous manifestations of systemic lupus erythematosus.
Yell JA; Mbuagbaw J; Burge SM
Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
